🇺🇸 Prevnar in United States

2,502 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 345 reports (13.79%)
  2. Drug Ineffective — 340 reports (13.59%)
  3. Asthma — 326 reports (13.03%)
  4. Off Label Use — 229 reports (9.15%)
  5. Chronic Obstructive Pulmonary Disease — 226 reports (9.03%)
  6. Pyrexia — 225 reports (8.99%)
  7. Fatigue — 210 reports (8.39%)
  8. Pain — 203 reports (8.11%)
  9. Therapeutic Product Effect Incomplete — 202 reports (8.07%)
  10. Gastrooesophageal Reflux Disease — 196 reports (7.83%)

Source database →

Prevnar in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Prevnar approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Prevnar in United States?

Abramson Cancer Center at Penn Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.